Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

Nuchal Translucency Study - PAPP-A

The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.

Inclusion Criteria:

• Female > 18 years old
• Pregnant

Exclusion Criteria:

• Maternal age < 18 years old, twin pregnancy